Aktis Oncology, Inc. · NASDAQ:AKTS
Herrmann Ken sold 4,856 Aktis Oncology, Inc. shares (Form 4)
Traded Jul 20, 2026 · Filed Jul 21, 2026
On Jul 20, 2026, Herrmann Ken (Director) sold 4,856 Aktis Oncology, Inc. shares at US$24.56 for US$119K, leaving 0 shares. Filed Jul 21, 2026 (Form 4).
- Sold
- 4,856 shares
- Price
- US$24.56
- Value
- US$119K
- Holding after
- 0 shares
- Trading plan
- No
- Role
- Director
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Jul 20, 2026 | Common Stock | Option exercise | 3,506 | US$0.08 | 3,506 | Direct |
| Jul 20, 2026 | Common Stock | Option exercise | 1,350 | US$1.91 | 4,856 | Direct |
| Jul 20, 2026 | Common Stock | Sale | 3,506 | US$24.56 | 1,350 | Direct |
| Jul 20, 2026 | Common Stock | Sale | 1,350 | US$24.56 | 0 | Direct |
Source
Related
- Aktis Oncology, Inc.
- Herrmann Ken
- Aktis Oncology, Inc. shareholders
- Form 4 · Herrmann Ken · Jul 20, 2026
- Form 4 · Czibere Akos · Sep 24, 2026
- Form 4 · Ron-Bigger Shulamit · Jul 10, 2026
- Form 4 · Czibere Akos · Jul 10, 2026
- Schedule 13G · Blue Owl Capital Holdings LP · May 14, 2026
- Schedule 13D · EcoR1 Capital, LLC · Jan 20, 2026